Stock comparison
Exelixis
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
EXEL
Exelixis
Market cap
$12.61B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Exelixis EXEL
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | EXEL | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 64C | 69B | MTD |
| Benjamin Graham | 74B | 65B | EXEL |
| Philip Fisher | 74B | 63C | EXEL |
| Peter Lynch | 58C | 66B | MTD |
| Joel Greenblatt | 60C | 68B | MTD |
| Charlie Munger | 71B | 74B | MTD |
| Terry Smith | 80A | 70B | EXEL |
Side-by-side metrics
| Metric | EXEL | MTD |
|---|---|---|
| Market cap | $12.61B | $22.29B |
| P/E (TTM) | 15.3x | 25.3x |
| EV/EBIT | 14.2x | 21.6x |
| ROIC (TTM) | 35.01% | 36.09% |
| Gross margin | 96.44% | 57.79% |
| Net margin | 35.08% | 21.4% |
| Revenue CAGR 5y | 12.76% | 2.01% |
| EPS CAGR 5y | 40.93% | 6.12% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
EXEL leads on
- EPS CAGR 5y40.93%vs 6.12%+85%
- Revenue CAGR 5y12.76%vs 2.01%+84%
- Gross margin96.44%vs 57.79%+40%
- P/E (TTM)15.3xvs 25.3x+39%
MTD leads on
- Debt / Equity-vs 0.1x+100%
- Market cap$22.29Bvs $12.61B+43%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.